Literature DB >> 15803162

Cortical inhibitory neurons and schizophrenia.

David A Lewis1, Takanori Hashimoto, David W Volk.   

Abstract

Impairments in certain cognitive functions, such as working memory, are core features of schizophrenia. Convergent findings indicate that a deficiency in signalling through the TrkB neurotrophin receptor leads to reduced GABA (gamma-aminobutyric acid) synthesis in the parvalbumin-containing subpopulation of inhibitory GABA neurons in the dorsolateral prefrontal cortex of individuals with schizophrenia. Despite both pre- and postsynaptic compensatory responses, the resulting alteration in perisomatic inhibition of pyramidal neurons contributes to a diminished capacity for the gamma-frequency synchronized neuronal activity that is required for working memory function. These findings reveal specific targets for therapeutic interventions to improve cognitive function in individuals with schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 15803162     DOI: 10.1038/nrn1648

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  967 in total

1.  Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

Authors:  Allison A Curley; Dominique Arion; David W Volk; Josephine K Asafu-Adjei; Allan R Sampson; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

2.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

3.  Estrogen Treatment Reverses Prematurity-Induced Disruption in Cortical Interneuron Population.

Authors:  Sanjeet Panda; Preeti Dohare; Samhita Jain; Nirzar Parikh; Pranav Singla; Rana Mehdizadeh; Damon W Klebe; George M Kleinman; Bokun Cheng; Praveen Ballabh
Journal:  J Neurosci       Date:  2018-07-23       Impact factor: 6.167

4.  Modulation of behavioral networks by selective interneuronal inactivation.

Authors:  M J Schmidt; S Horvath; P Ebert; J L Norris; E H Seeley; J Brown; L Gellert; M Everheart; K A Garbett; T W Grice; R M Caprioli; K Mirnics
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

5.  Dopamine D4 Receptors Regulate GABAA Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism.

Authors:  Nicholas M Graziane; Eunice Y Yuen; Zhen Yan
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

Review 6.  BDNF-TrkB signaling and neuroprotection in schizophrenia.

Authors:  Chirayu D Pandya; Ammar Kutiyanawalla; Anilkumar Pillai
Journal:  Asian J Psychiatr       Date:  2012-11-03

7.  BDNF Val66Met polymorphism tunes frontolimbic circuitry during affective contextual learning.

Authors:  Mbemba Jabbi; Brett Cropp; Tiffany Nash; Philip Kohn; J Shane Kippenhan; Joseph C Masdeu; Raghav Mattay; Bhaskar Kolachana; Karen F Berman
Journal:  Neuroimage       Date:  2017-09-01       Impact factor: 6.556

Review 8.  Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 9.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

10.  Dynamic changes of functional segregation and integration in vulnerability and resilience to schizophrenia.

Authors:  Jia Duan; Mingrui Xia; Fay Y Womer; Miao Chang; Zhiyang Yin; Qian Zhou; Yue Zhu; Zhuang Liu; Xiaowei Jiang; Shengnan Wei; Francis Anthony O'Neill; Yong He; Yanqing Tang; Fei Wang
Journal:  Hum Brain Mapp       Date:  2019-01-15       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.